Patents by Inventor Susan Dina Ghiassian

Susan Dina Ghiassian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND SYSTEMS FOR PREDICTING RESPONSE TO ANTI-TNF THERAPIES
    Publication number: 20220056121
    Abstract: Methods and systems for administering anti-TNF therapy to subjects who have been determined to display a gene expression response signature established to distinguish between responsive and non-responsive prior subjects who have received the anti-TNF therapy.
    Type: Application
    Filed: November 2, 2021
    Publication date: February 24, 2022
    Inventors: Keith J. JOHNSON, Susan Dina GHIASSIAN
  • Methods and systems for predicting response to anti-TNF therapies
    Patent number: 11198727
    Abstract: Methods and systems for administering anti-TNF therapy to subjects who have been determined to display a gene expression response signature established to distinguish between responsive and non-responsive prior subjects who have received the anti-TNF therapy.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: December 14, 2021
    Assignee: SCIPHER MEDICINE CORPORATION
    Inventors: Keith J. Johnson, Susan Dina Ghiassian
  • Method of treating a subject suffering from rheumatoid arthritis with anti-TNF therapy based on a trained machine learning classifier
    Patent number: 11195595
    Abstract: Presented herein are systems and methods for developing classifiers useful for predicting response to particular treatments. For example, in some embodiments, the present disclosure provides a method of treating subjects suffering from an autoimmune disorder, the method comprising a step of: administering an anti-TNF therapy to subjects who have been determined to be responsive via a classifier established to distinguish between responsive and non-responsive prior subjects in a cohort who have received the anti-TNF therapy.
    Type: Grant
    Filed: May 10, 2021
    Date of Patent: December 7, 2021
    Assignee: SCIPHER MEDICINE CORPORATION
    Inventors: Susan Dina Ghiassian, Theodore R. Mellors, Marc Santolini, Asher Ameli, Nancy Schoenbrunner, Viatcheslav R. Akmaev, Keith J. Johnson
  • DEVELOPING CLASSIFIERS FOR STRATIFYING PATIENTS
    Publication number: 20210280271
    Abstract: Presented herein are systems and methods for developing classifiers useful for predicting response to particular treatments. For example, in some embodiments, the present disclosure provides a method of treating subjects suffering from an autoimmune disorder, the method comprising a step of: administering an anti-TNF therapy to subjects who have been determined to be responsive via a classifier established to distinguish between responsive and non-responsive prior subjects in a cohort who have received the anti-TNF therapy.
    Type: Application
    Filed: May 10, 2021
    Publication date: September 9, 2021
    Inventors: Susan Dina Ghiassian, Theodore R. Mellors, Marc Santolini, Asher Ameli, Nancy Schoenbrunner, Viatcheslav R. Akmaev, Keith J. Johnson
  • METHODS AND SYSTEMS FOR PREDICTING RESPONSE TO ANTI-TNF THERAPIES
    Publication number: 20190284270
    Abstract: Methods and systems for administering anti-TNF therapy to subjects who have been determined to display a gene expression response signature established to distinguish between responsive and non-responsive prior subjects who have received the anti-TNF therapy.
    Type: Application
    Filed: April 25, 2019
    Publication date: September 19, 2019
    Inventors: Keith J. Johnson, Susan Dina Ghiassian